Citigroup’s Odonate Therapeutics, Inc. Common Stock ODT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-1,959
| Closed | -$6K | – | 5358 |
|
|
2021
Q3 | $6K | Sell |
1,959
-375
| -16% | -$1.15K | ﹤0.01% | 4813 |
|
|
2021
Q2 | $8K | Sell |
2,334
-187,910
| -99% | -$644K | ﹤0.01% | 5073 |
|
|
2021
Q1 | $651K | Buy |
190,244
+181,550
| +2,088% | +$621K | ﹤0.01% | 2660 |
|
|
2020
Q4 | $167K | Buy |
8,694
+7,881
| +969% | +$151K | ﹤0.01% | 3346 |
|
|
2020
Q3 | $11K | Sell |
813
-19,041
| -96% | -$258K | ﹤0.01% | 4284 |
|
|
2020
Q2 | $841K | Buy |
19,854
+17,057
| +610% | +$723K | ﹤0.01% | 2224 |
|
|
2020
Q1 | $77K | Buy |
2,797
+399
| +17% | +$11K | ﹤0.01% | 3477 |
|
|
2019
Q4 | $78K | Buy |
2,398
+1,339
| +126% | +$43.6K | ﹤0.01% | 3688 |
|
|
2019
Q3 | $28K | Sell |
1,059
-1,111
| -51% | -$29.4K | ﹤0.01% | 4097 |
|
|
2019
Q2 | $80K | Buy |
2,170
+330
| +18% | +$12.2K | ﹤0.01% | 3779 |
|
|
2019
Q1 | $41K | Buy |
1,840
+52
| +3% | +$1.16K | ﹤0.01% | 4152 |
|
|
2018
Q4 | $25K | Sell |
1,788
-74
| -4% | -$1.04K | ﹤0.01% | 4327 |
|
|
2018
Q3 | $36K | Buy |
1,862
+886
| +91% | +$17.1K | ﹤0.01% | 4280 |
|
|
2018
Q2 | $22K | Buy |
976
+86
| +10% | +$1.94K | ﹤0.01% | 4350 |
|
|
2018
Q1 | $19K | Buy |
+890
| New | +$19K | ﹤0.01% | 4251 |
|